Hien Thi Tran

Array ( [id] => 520646 [patent_doc_number] => 07186515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-06 [patent_title] => 'Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/625137 [patent_app_country] => US [patent_app_date] => 2000-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 16 [patent_no_of_words] => 33248 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186515.pdf [firstpage_image] =>[orig_patent_app_number] => 09625137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575774 [patent_doc_number] => 07452534 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-18 [patent_title] => 'Recombinant anti-CD4 antibodies for human therapy' [patent_app_type] => utility [patent_app_number] => 09/612914 [patent_app_country] => US [patent_app_date] => 2000-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 28 [patent_no_of_words] => 22383 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452534.pdf [firstpage_image] =>[orig_patent_app_number] => 09612914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506394 [patent_doc_number] => 07202342 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-04-10 [patent_title] => 'Compositions and methods for the therapy and diagnosis of prostate cancer' [patent_app_type] => utility [patent_app_number] => 09/570737 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 62213 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202342.pdf [firstpage_image] =>[orig_patent_app_number] => 09570737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535240 [patent_doc_number] => 07176179 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-13 [patent_title] => 'Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide' [patent_app_type] => utility [patent_app_number] => 09/569698 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 21701 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176179.pdf [firstpage_image] =>[orig_patent_app_number] => 09569698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690335 [patent_doc_number] => 07074613 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-11 [patent_title] => 'Monoclonal antibody directed against cells of human renal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 09/959911 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 4196 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074613.pdf [firstpage_image] =>[orig_patent_app_number] => 09959911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 788054 [patent_doc_number] => 06986986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-17 [patent_title] => 'Polyvalent display libraries' [patent_app_type] => utility [patent_app_number] => 09/563055 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 26402 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/986/06986986.pdf [firstpage_image] =>[orig_patent_app_number] => 09563055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1219647 [patent_doc_number] => 06703020 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Antibody conjugate methods for selectively inhibiting VEGF' [patent_app_type] => B1 [patent_app_number] => 09/561005 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92113 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703020.pdf [firstpage_image] =>[orig_patent_app_number] => 09561005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020833 [patent_doc_number] => 06887468 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Antibody kits for selectively inhibiting VEGF' [patent_app_type] => utility [patent_app_number] => 09/562245 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 87816 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887468.pdf [firstpage_image] =>[orig_patent_app_number] => 09562245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1109831 [patent_doc_number] => 06805864 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Type I angiotensin II receptor specific monoclonal antibodies and hybridomas' [patent_app_type] => B1 [patent_app_number] => 09/540816 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3045 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/805/06805864.pdf [firstpage_image] =>[orig_patent_app_number] => 09540816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7617184 [patent_doc_number] => 06946256 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-20 [patent_title] => 'Cell regulatory genes, encoded products, and uses related thereto' [patent_app_type] => utility [patent_app_number] => 09/538106 [patent_app_country] => US [patent_app_date] => 2000-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 32 [patent_no_of_words] => 53805 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946256.pdf [firstpage_image] =>[orig_patent_app_number] => 09538106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711512 [patent_doc_number] => 20030171261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Fucosyl gm1-klh conjugate vaccine against small cell lung cancer' [patent_app_type] => new [patent_app_number] => 09/534711 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14500 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171261.pdf [firstpage_image] =>[orig_patent_app_number] => 09534711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331743 [patent_doc_number] => 06596534 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Utilization of osteocalcin promoter to deliver therapeutic genes to tumors' [patent_app_type] => B1 [patent_app_number] => 09/534414 [patent_app_country] => US [patent_app_date] => 2000-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6095 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596534.pdf [firstpage_image] =>[orig_patent_app_number] => 09534414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872633 [patent_doc_number] => 07361730 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-22 [patent_title] => 'Surface localized colligin/Hsp47 in carcinoma cells' [patent_app_type] => utility [patent_app_number] => 09/936565 [patent_app_country] => US [patent_app_date] => 2000-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15895 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361730.pdf [firstpage_image] =>[orig_patent_app_number] => 09936565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826643 [patent_doc_number] => 07402306 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-22 [patent_title] => 'Cancer immunotherapy with semi-allogeneic cells' [patent_app_type] => utility [patent_app_number] => 09/522716 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19779 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402306.pdf [firstpage_image] =>[orig_patent_app_number] => 09522716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536801 [patent_doc_number] => 07176289 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-13 [patent_title] => 'Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/516728 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 34 [patent_no_of_words] => 29674 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176289.pdf [firstpage_image] =>[orig_patent_app_number] => 09516728 [rel_patent_id] =>[rel_patent_doc_number] =>)